Showing 2731-2740 of 19323 results for "".
LDL Apheresis
https://reachmd.com/programs/lipid-luminations/ldl-apheresis-1/6475/About 1 in 500 people have familial hypercholesterolemia (FH), the genetic disorder characterised by very high levels of low-density lipoprotein in the blood. Host Dr. Alan Brown talks to Dr. James Falko, professor of medicine in the division of endocrinology, metabolism and diabetes at the UniversA Holistic Approach to Skincare: Partnering with the Aesthetic Patient
https://reachmd.com/ma-supplements/2022-mar-apr-insert/a-holistic-approach-to-skincare-partnering-with-the-aesthetic-patient/35158/Beyond offering patients the latest innovative treatments, aesthetic physicians stress the importance of caring for patients’ overall skin healthTargeting Inflammation to Improve Gene Therapy Outcomes in Sickle Cell Disease
https://reachmd.com/programs/clinicians-roundtable/Targeting-Inflammation-to-Improve-Gene-Therapy-Outcomes-in-Sickle-Cell-Disease/35926/Women in Aesthetics: Alesheia Randolph Bush, MBA
https://reachmd.com/ma-issues-index/2025-mar-apr/women-in-aesthetics-alesheia-randolph-bush-mba/36072/Get to know Alesheia Randolph Bush, MBA, VP-Global Professional + Industry Relations for ZO Skin Health, Inc.Fluid Foundations: How Location Impacts Outcomes in nAMD
https://reachmd.com/programs/cme/Fluid-Foundations-How-Location-Impacts-Outcomes-in-nAMD-2510/33126/Hear about new biomarkers for assessing retinal disease activity and their clinical significance when using of second-generation agents.The Impact of Pharmacy Issues in Long-Term Care
https://reachmd.com/programs/advances-in-long-term-care-medicine/the-impact-of-pharmacy-issues-in-long-term-care/5896/As medication costs continue rising, what strategies can help long-term care facilities reduce drug expenditures, while still providing the best quality of care for patients? Fred Wendt, RPh, vice president of pharmacy services for Senior PharmaStrategies in Burleson, Texas, says one of the most sigTargeting B7-H3 in ES-SCLC: Advancing Targeted Therapy Through Evidence-Based Innovation and Multidisciplinary Care
https://reachmd.com/programs/cme/targeting-b7-h3-in-es-sclc-advancing-targeted-therapy-through-evidence-based-innovation-and-multidisciplinary-care/36232/Explore the rationale and emerging efficacy and safety data for B7-H3–targeted ADCs in ES-SCLC to support patient selection and multidisciplinary care.Looking Ahead: Integrating CDH6-Targeted Therapies Into Ovarian Cancer Treatment Paradigms
https://reachmd.com/programs/cme/looking-ahead-integrating-cdh6-targeted-therapies-into-ovarian-cancer-treatment-paradigms/37866/CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian CancerImplementing Guideline-Concordant Care for a Patient With Newly Diagnosed BRAF-Mutant Stage IV Melanoma
https://reachmd.com/programs/cme/implementing-guideline-concordant-care-for-a-patient-with-newly-diagnosed-braf-mutant-stage-iv-melanoma/36328/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Recognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact
https://reachmd.com/programs/neurofrontiers/recognizing-multiple-sclerosis-awareness-month-ways-to-make-an-impact/32369/March is Multiple Sclerosis Awareness Month. Learn about how you can support patients and raise awareness through education, advocacy, and community engagement.